Protara Therapeutics
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -90 | -93 | ||
EBITDA | -23,154 | -21,596 | -17,692 | -17,214 |
EBIT | -23,154 | -21,668 | -17,782 | -17,307 |
Net Income | -21,688 | -21,668 | -17,782 | -17,307 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,165 | -15,721 | -21,343 | -16,974 |
Cash | 25,150 | 17,076 | 14,737 | 49,657 |
Basic Shares | 62,850 | 61,006 | 57,538 | 46,041 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -362 | -332 | -341 | -247 |
EBITDA | -57,077 | -44,264 | -40,079 | -64,567 |
EBIT | -57,439 | -44,596 | -40,420 | -64,815 |
Net Income | -57,439 | -44,596 | -40,420 | -65,952 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -56,459 | -35,871 | -37,602 | -26,577 |
Cash | 49,657 | 162,798 | 39,586 | 24,127 |
Basic Shares | 42,836 | 20,592 | 11,331 | 11,259 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.35 |
2026-06-30 | -$0.36 |
2026-03-31 | -$0.31 |
2025-12-31 | -$0.38 |